Loading...
Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features
BACKGROUND: Risk of prostate cancer-specific mortality (PCSM) is highly variable for men with adverse pathologic features at radical prostatectomy (RP); a majority will die of other causes. Accurately stratifying PCSM risk can improve therapy decisions. OBJECTIVE: Validate the 22 gene Decipher genom...
Na minha lista:
| Udgivet i: | Eur Urol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5632569/ https://ncbi.nlm.nih.gov/pubmed/28400167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2017.03.036 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|